Investing

Verrica Pharmaceuticals : VRCA

VRCA

Stock Data

$6.27

$0.10 (1.57%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Verrica Pharmaceuticals Inc is a pioneering dermatology-focused biopharmaceutical company. It specializes in developing innovative treatments for skin diseases, including common and genital warts, basal cell carcinoma, and plantar warts. Its leading product, YCANTH (VP-102), is making strides in phase III trials for common warts and has shown promise in other skin conditions. The company also explores cancer treatments with VP-315 and targets plantar warts with VP-103. Founded in 2013 and based in West Chester, Pennsylvania, Verrica Pharmaceuticals is committed to advancing dermatological care worldwide.

All Verrica Pharmaceuticals Articles

2 Articles

Trey Thoelcke | Dec 31, 2023 at 10:10 AM EST

Here’s What Insiders Are Buying to Wrap Up the Year

As the year wound to a close, the most notable insider buying was focused on biotech stocks, but an oil…

Trey Thoelcke | Dec 23, 2023 at 9:03 AM EST

Buffett, Dollar Tree Purchases Highlight Pre-Christmas Insider Buying

Warren Buffett's Berkshire Hathaway has again bolstered its stake in Occidental Petroleum, and action at Dollar Tree also highlights recent…